Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS known ✓ | P14324 | 1/20 | 0.39 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.39 |
| ▸ | THRA known ✓ | P10827 | 1/20 | 0.37 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625084 | 1.00 | S1PR2 (0.46) | S1PR2S1PR1S1PR3S1PR5DNM1 | |
| SCHEMBL30343169 | 1.00 | S1PR2 (0.46) | S1PR2S1PR1S1PR3S1PR5DNM1 | |
| SCHEMBL1728405 | 1.00 | S1PR2 (0.46) | S1PR2S1PR1S1PR3S1PR5DNM1 | |
| SCHEMBL6402056 | 0.98 | S1PR2 (0.43) | S1PR2S1PR1S1PR3S1PR5DNM1 | |
| SCHEMBL8388882 | 0.90 | EPHX2 (0.52) | S1PR2S1PR1S1PR3S1PR5EPHX2 | |
| SCHEMBL82226 | 0.90 | EPHX2 (0.52) | S1PR2S1PR1S1PR3S1PR5EPHX2 | |
| Potassium Ion SCHEMBL1820922 | 0.87 | EPHX2 (0.49) | EPHX2FAAH | |
| Taurine SCHEMBL31682421 | 0.86 | LMNA (0.40) | S1PR2S1PR1S1PR3S1PR5RECQL | |
| Taurine SCHEMBL30343181 | 0.83 | S1PR2 (0.40) | S1PR2S1PR1S1PR3S1PR5RECQL | |
| SCHEMBL2925349 | 0.78 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578161-B1 | METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC | ADEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| WO-2022138425-A1 | WATER-IN-OIL TYPE EMULSION COSMETIC | 株式会社 資生堂 | 2022-06-30 | — | — | WO | disclosed |
| CN-111212626-A | Antibacterial composition and cosmetic containing the same | 株式会社ADEKA | 2020-05-29 | — | — | CN | disclosed |
| CN-111065368-A | Multi-layer powder cosmetic | 株式会社资生堂 | 2020-04-24 | — | — | CN | disclosed |
| CN-111050736-A | Antibacterial and antifungal composition | 株式会社ADEKA | 2020-04-21 | — | — | CN | disclosed |
| CN-110868990-A | Color cosmetic | 株式会社资生堂 | 2020-03-06 | — | — | CN | disclosed |
| CN-110769802-A | Solid powder cosmetic | 株式会社资生堂 | 2020-02-07 | — | — | CN | disclosed |
| EP-3578161-A1 | METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC | Adeka Corporation (JP) | 2019-12-11 | — | — | EP | disclosed |
| US-10307366-B2 | Composition and related method for inhibiting moisture loss from skin | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2019-06-04 | — | — | US | disclosed |
| US-20190160117-A1 | METHOD AND TOPICAL COMPOSITION FOR MODIFICATION OF A SKIN MICROBIOME | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2019-05-30 | — | — | US | disclosed |
| EP-0797984-B1 | Anti-aging cosmetic composition | SHISEIDO CO LTD (JP) | 2005-02-16 | — | — | EP | disclosed |
| WO-2004084646-A2 | COSMETIC COMPOSITIONS COMPRISING PHYTOSTEROL ESTERS | ENZYMOTEC LTD. (IL) | 2004-10-07 | — | — | WO | disclosed |
| EP-0815838-B1 | External skin treatment composition | SHISEIDO CO LTD (JP) | 2004-04-28 | — | — | EP | disclosed |
| US-6419962-B1 | PLANT EXTRACT IN CARRIER | SHISEIDO COMPANY, LTD. (JP) | 2002-07-16 | — | — | US | disclosed |
| US-20020041889-A1 | ENHANCING AGENT FOR DEGRADATION OF DESMOSOMES OR STRATUM CORNEUM DESQUAMATION | SHISEIDO COMPANY, LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-5853705-A | Anti-aging cosmetic composition | SHISEIDO COMPANY, LTD. (JP) | 1998-12-29 | — | — | US | disclosed |
| EP-0852949-A2 | Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation | SHISEIDO COMPANY LIMITED (JP) | 1998-07-15 | — | — | EP | disclosed |
| EP-0815838-A2 | External skin treatment composition | SHISEIDO COMPANY, LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
| EP-0797984-A2 | Anti-aging cosmetic composition | SHISEIDO COMPANY LIMITED (JP) | 1997-10-01 | — | — | EP | disclosed |
| EP-0726314-A1 | FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) | LION CORPORATION (JP) | 1996-08-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041889-A1 | ENHANCING AGENT FOR DEGRADATION OF DESMOSOMES OR STRATUM CORNEUM DESQUAMATION | DSG1, DSC1, CUTA | FDPS 3806/4885PDE3A 1225/4885THRA 4115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.